Transplantation
Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations
Abstract
Cytomegalovirus (CMV) continues to cause significant morbidity and mortality in lung transplant recipients. This article presents recommendations based on available evidence for the optimal management of CMV in lung transplant recipients, which have been developed by an expert committee of transplant physicians-surgeons and infectious disease specialists.
Source and rights
Published by Transplantation, 2005. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2005
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Transplantation
- PubMed
- 16041258
- Added to Prognia
- 23 July 2026
More in surgery
- American Society for Metabolic and Bariatric Surgery review of endobariatric proceduresAmerican Society for Metabolic and Bariatric Surgery · 2026
- Non-pneumatic compression and its clinical utility in management of lymphedema. A position statement endorsed by the American Venous Forum and the American Venous and Lymphatic SocietyAmerican Venous Forum and American Venous and Lymphatic Society · 2026
